-
公开(公告)号:US09610288B2
公开(公告)日:2017-04-04
申请号:US14333368
申请日:2014-07-16
Applicant: FOUNDATION MEDICINE, INC.
Inventor: Siraj Mahamed Ali , Matthew J. Hawryluk , Jeffrey S. Ross , Philip James Stephens
IPC: C12Q1/68 , A61K31/517 , A61K47/48 , A61K31/5365 , C07K14/82 , C07K16/32 , A61K45/06 , A61K31/475 , A61K31/519 , A61K31/704 , A61K31/7105 , A61K31/713 , A61K33/24
Abstract: Methods and compositions for treating a urothelial and/or a micropapillary carcinoma, such as a micropapillary urothelial carcinoma are disclosed.
-
42.
公开(公告)号:US09410954B2
公开(公告)日:2016-08-09
申请号:US14177615
申请日:2014-02-11
Applicant: FOUNDATION MEDICINE, INC. , UCL Business PLC
Inventor: Chris Hendrik Boshoff , Timothy Robert Fenton , Matthias Alexander Lechner , Philip James Stephens , Matthew J. Hawryluk , Garrett Michael Frampton , Roman Yelensky
IPC: A61K31/513 , A61K31/555 , A61K31/337 , A61K33/24 , G01N33/571 , C07K16/28 , C12Q1/68 , C12Q1/70 , A61K31/506 , A61K31/519 , A61K31/454 , A61K31/52 , A61K31/404 , A61K31/4196 , A61K31/282 , A61K39/395 , A61K31/436 , A61K31/05 , A61K31/4709 , A61K31/496 , A61K31/5377 , A61K31/352 , A61N5/00 , A61K31/366 , A61K31/505 , A61K31/439 , A61K31/4745 , A61K39/00
CPC classification number: A61K31/519 , A61K31/05 , A61K31/282 , A61K31/337 , A61K31/352 , A61K31/366 , A61K31/404 , A61K31/4196 , A61K31/436 , A61K31/439 , A61K31/454 , A61K31/4709 , A61K31/4745 , A61K31/496 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/52 , A61K31/5377 , A61K31/555 , A61K33/24 , A61K39/39558 , A61K2039/505 , A61N5/00 , A61N5/10 , C07K16/2863 , C12Q1/6883 , C12Q1/6886 , C12Q1/708 , C12Q2600/106 , C12Q2600/118 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G01N33/571 , A61K2300/00
Abstract: Methods of treating a head and neck cancer are disclosed.
Abstract translation: 公开了治疗头颈癌的方法。
-
公开(公告)号:US20150366866A1
公开(公告)日:2015-12-24
申请号:US14761518
申请日:2014-01-17
Applicant: Vincent A. Miller , FOUNDATION MEDICINE, INC.
Inventor: Siraj Mahamed Ali , Matthew J. Hawryluk , Jie He , Doron Lipson , Vincent A. Miller , Jeffrey S. Ross , Philip James Stephens
IPC: A61K31/5025 , C07K16/40 , C12Q1/68 , G01N33/573 , C12N9/12 , A61K31/4412 , C12N15/113
CPC classification number: A61K31/5025 , A61K31/404 , A61K31/435 , A61K31/4412 , A61K31/4439 , A61K31/47 , A61K31/496 , A61K31/498 , A61K31/506 , A61K31/517 , A61K31/519 , A61K31/53 , A61K31/5383 , A61K31/553 , A61K45/06 , C07K14/705 , C07K14/71 , C07K16/40 , C07K2319/00 , C12N9/12 , C12N15/1137 , C12N2310/11 , C12N2310/12 , C12N2310/14 , C12Q1/6883 , C12Q1/6886 , C12Q2600/156 , C12Q2600/158 , C12Y207/10001 , G01N33/573 , G01N2333/912 , G01N2500/04
Abstract: Methods and compositions for treating cholangiocarcinoma.
Abstract translation: 治疗胆管癌的方法和组合物。
-
公开(公告)号:US20150046191A1
公开(公告)日:2015-02-12
申请号:US14463073
申请日:2014-08-19
Applicant: FOUNDATION MEDICINE, INC.
Inventor: Helena Futscher de Deus , Rachel Lauren Erlich , Ronald David Collette , Alexander N. Parker , Michael Pellini , Gary Palmer , Mary Pat Lancelotta , Matthew J. Hawryluk , Philip James Stephens , Eric Karl Neumann , Jeffrey B. Collemer
IPC: G06F19/00
CPC classification number: G16H10/60 , G06F19/3456 , G06Q50/24 , G16C99/00 , G16H15/00
Abstract: Various embodiments provide interfaces to access genomic testing information and incorporate it into daily physician practice. According to one aspect, a graph-based data model is used that may be used to organizes and revise precision medicine knowledge. In one example structure, gene states are abstracted into alteration groups, where alteration groups are built using reverse engineering actionable information and storing that information within the graph-based data structure. Volumes of genomic alterations and associated information (e.g., journal articles, clinical trial information, therapies, etc.) are analyzed and synthesized into actionable information items viewable on an alteration system in a graph-based data format. According to one embodiment, the system can be configured to focus practitioners on discrete portions of the alteration information on which they can act. According to other aspects, curated information is provided on the system to enable practitioners to make informed decisions regarding the implications of the presence of specific genomic alterations.
-
公开(公告)号:US20150046180A1
公开(公告)日:2015-02-12
申请号:US14463068
申请日:2014-08-19
Applicant: FOUNDATION MEDICINE, INC.
Inventor: Helena Futscher de Deus , Rachel Lauren Erlich , Ronald David Collette , Alexander N. Parker , Michael Pellini , Gary Palmer , Mary Pat Lancelotta , Matthew J. Hawryluk , Philip James Stephens , Eric Karl Neumann
IPC: G06F19/00
Abstract: Various embodiments provide interfaces to access genomic testing information and incorporate it into daily physician practice. According to one aspect, a graph-based data model is used that may be used to organizes and revise precision medicine knowledge. In one example structure, gene states are abstracted into alteration groups, where alteration groups are built using reverse engineering actionable information and storing that information within the graph-based data structure. Volumes of genomic alterations and associated information (e.g., journal articles, clinical trial information, therapies, etc.) are analyzed and synthesized into actionable information items viewable on an alteration system in a graph-based data format. According to one embodiment, the system can be configured to focus practitioners on discrete portions of the alteration information on which they can act. According to other aspects, curated information is provided on the system to enable practitioners to make informed decisions regarding the implications of the presence of specific genomic alterations.
Abstract translation: 各种实施方案提供了接口以访问基因组测试信息并将其并入日常医师实践中。 根据一个方面,使用可用于组织和修改精密医学知识的基于图的数据模型。 在一个示例结构中,基因状态被抽象为变更组,其中使用反向工程可操作信息构建变更组,并将该信息存储在基于图的数据结构内。 将基因组变化和相关信息(例如,期刊文章,临床试验信息,治疗等)的卷分析并合成为以基于图表的数据格式在变更系统上可见的可操作的信息项。 根据一个实施例,系统可以被配置为将从业者聚焦在它们可以作用于其上的变更信息的离散部分上。 根据其他方面,在系统上提供了策划的信息,以使从业者就具体基因组改变的存在的含义做出明智的决定。
-
46.
公开(公告)号:US20150030587A1
公开(公告)日:2015-01-29
申请号:US14177615
申请日:2014-02-11
Applicant: Foundation Medicine, Inc.
Inventor: Chris Hendrik Boshoff , Timothy Robert Fenton , Matthias Alexander Lechner , Philip James Stephens , Matthew J. Hawryluk , Garrett Michael Frampton , Roman Yelensky
IPC: G01N33/571 , C07K16/28 , A61K31/513 , A61K31/555 , A61K31/337 , A61K31/366 , C12Q1/68 , A61K31/439 , A61K31/05 , A61K31/4745 , A61K31/496 , A61K31/5377 , A61K33/24 , C12Q1/70
CPC classification number: A61K31/519 , A61K31/05 , A61K31/282 , A61K31/337 , A61K31/352 , A61K31/366 , A61K31/404 , A61K31/4196 , A61K31/436 , A61K31/439 , A61K31/454 , A61K31/4709 , A61K31/4745 , A61K31/496 , A61K31/505 , A61K31/506 , A61K31/513 , A61K31/52 , A61K31/5377 , A61K31/555 , A61K33/24 , A61K39/39558 , A61K2039/505 , A61N5/00 , A61N5/10 , C07K16/2863 , C12Q1/6883 , C12Q1/6886 , C12Q1/708 , C12Q2600/106 , C12Q2600/118 , C12Q2600/156 , C12Q2600/158 , C12Q2600/16 , G01N33/571 , A61K2300/00
Abstract: Methods of treating a head and neck cancer are disclosed.
Abstract translation: 公开了治疗头颈癌的方法。
-
47.
公开(公告)号:US20140243390A1
公开(公告)日:2014-08-28
申请号:US14187280
申请日:2014-02-23
Applicant: FOUNDATION MEDICINE, INC.
Inventor: Sean R. Downing , Matthew J. Hawryluk , Doron Lipson , Alexander N. Parker , Philip James Stephens
IPC: C12N15/113 , A61K31/47 , A61K31/513 , A61K31/517 , A61K31/444 , A61K31/4412 , A61K31/404
CPC classification number: A61K31/517 , A61K31/404 , A61K31/4412 , A61K31/444 , A61K31/47 , A61K31/513 , C07K14/82 , C07K2319/00 , C12N9/14 , C12N15/1135 , C12Q1/6886 , C12Q2600/136 , C12Q2600/156 , C12Q2600/158
Abstract: Novel RET fusion molecules and uses are disclosed.
Abstract translation: 公开了新型RET融合分子和用途。
-
公开(公告)号:US20140221329A1
公开(公告)日:2014-08-07
申请号:US14251856
申请日:2014-04-14
Applicant: FOUNDATION MEDICINE, INC.
Inventor: Maureen T. Cronin , Garrett Michael Frampton , Doron Lipson , Vincent A. Miller , Gary Palmer , Jeffrey S. Ross , Philip James Stephens , Roman Yelensky
IPC: C12Q1/68 , A61K31/439 , A61K31/567
CPC classification number: C12Q1/6886 , A61K31/416 , A61K31/4196 , A61K31/423 , A61K31/428 , A61K31/436 , A61K31/437 , A61K31/439 , A61K31/4439 , A61K31/472 , A61K31/536 , A61K31/5415 , A61K31/565 , A61K31/567 , A61K31/675 , A61K45/06 , C07K14/72 , C07K16/2869 , C07K2317/34 , C12Q2600/106 , C12Q2600/118 , C12Q2600/156
Abstract: Novel mutant ESR1 molecules and uses are disclosed.
Abstract translation: 公开了新型突变体ESR1分子和用途。
-
-
-
-
-
-
-